Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetylcysteine (mucomyst) (1 trial)
acetylsalicylic acid (aspirin) (1 trial)
sodium chloride (2 trials)
tranexamic acid (cyklokapron) (1 trial)
platelet-rich plasma (1 trial)
vitamin d3 (1 trial)
bromocriptine (parlodel) (1 trial)
bupivacaine (Exparel) (1 trial)
cabergoline (dostinex) (1 trial)
dabigatran (pradaxa) (1 trial)
enoxaparin (lovenox) (1 trial)
omeprazole (prilosec) (1 trial)
oseltamivir (tamiflu) (1 trial)
rivaroxaban (xarelto) (1 trial)
ropivacaine (naropin) (1 trial)
sodium butyrate (1 trial)
Atrophy (Phase 4)
Congenital Abnormalities (Phase 4)
Gastrointestinal Hemorrhage (Phase 4)
Hemorrhage (Phase 4)
Infant, Premature, Diseases (Phase 3)
Premature Birth (Phase 3)
Trials (12 total)
Trial APIs (16 total)